On the public citation graph
Prognostic Factors and Models for Non-Metastatic Renal Cell Carcinoma
0 signed · 109 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/(sici)1097-0215(19970729)72:3<424::aid-ijc9>3.0.co;2-ropenalex-extracted
Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma
inferredcites →https://doi.org/10.1002/cam4.1790openalex-extracted
Modification of American Joint Committee on cancer prognostic groups for renal cell carcinoma
inferredcites →https://doi.org/10.1002/cam4.4595openalex-extracted
The impact of tumor size on the survival of patients with small renal masses: A population–based study
inferredcites →https://doi.org/10.1002/cncr.21331openalex-extracted
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy
inferredcites →https://doi.org/10.1002/cncr.31661openalex-extracted
Renal cell carcinoma and pathologic nodal disease: Implications for American Joint Committee on Cancer staging
inferredcites →https://doi.org/10.1002/cncr.33462openalex-extracted
Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma
inferredcites →https://doi.org/10.1007/s00345-010-0526-6openalex-extracted
Urinary collecting system invasion is no independent prognostic factor in renal cell carcinoma
inferredcites →https://doi.org/10.1007/s00345-015-1747-5openalex-extracted
Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion
inferredcites →https://doi.org/10.1007/s00432-015-1908-3openalex-extracted
Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort
inferredcites →https://doi.org/10.1007/s00432-023-05204-0openalex-extracted
Prognostic value of preoperative microscopic hematuria in patients with non-metastatic renal cell carcinoma who underwent nephrectomy
inferredcites →https://doi.org/10.1007/s10147-017-1172-4openalex-extracted
Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma
inferredcites →https://doi.org/10.1007/s11255-023-03724-9openalex-extracted
Validation and comparison of prognostic value of different preoperative systemic inflammation indices in non-metastatic renal cell carcinoma
inferredcites →https://doi.org/10.1016/j.ccell.2015.02.015openalex-extracted
Macrophages and Therapeutic Resistance in Cancer
inferredcites →https://doi.org/10.1016/j.clgc.2014.12.001openalex-extracted
Using Percentage of Sarcomatoid Differentiation as a Prognostic Factor in Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/j.clgc.2022.01.012openalex-extracted
Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Factor in Patients Undergoing Nephrectomy for Non-Metastatic Renal Cell Carcinoma: Propensity Score Matching Analysis
inferredcites →https://doi.org/10.1016/j.clgc.2022.03.004openalex-extracted
Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort
inferredcites →https://doi.org/10.1016/j.euros.2023.05.005openalex-extracted
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/j.eururo.2004.07.006openalex-extracted
Prognostic Value of the Involvement of the Urinary Collecting System in Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/j.eururo.2005.04.016openalex-extracted
Histological Subtyping and Nuclear Grading of Renal Cell Carcinoma and Their Implications for Survival: A Retrospective Nation-Wide Study of 629 Patients
inferredcites →https://doi.org/10.1016/j.eururo.2008.11.033openalex-extracted
External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
inferredcites →https://doi.org/10.1016/j.eururo.2010.07.006openalex-extracted
Validation of the 2009 TNM Version in a Large Multi-Institutional Cohort of Patients Treated for Renal Cell Carcinoma: Are Further Improvements Needed?
inferredcites →https://doi.org/10.1016/j.eururo.2011.06.041openalex-extracted
Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
inferredcites →https://doi.org/10.1016/j.eururo.2014.02.035openalex-extracted
ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/j.eururo.2015.02.001openalex-extracted
Five-year Analysis of a Multi-institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry
inferredcites →https://doi.org/10.1016/j.eururo.2015.09.027openalex-extracted
Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas
inferredcites →https://doi.org/10.1016/j.eururo.2016.02.029openalex-extracted
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
inferredcites →https://doi.org/10.1016/j.eururo.2016.05.034openalex-extracted
Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients
inferredcites →https://doi.org/10.1016/j.eururo.2017.12.002openalex-extracted
A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/j.eururo.2017.12.018openalex-extracted
Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers
inferredcites →https://doi.org/10.1016/j.eururo.2018.01.005openalex-extracted
Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery
inferredcites →https://doi.org/10.1016/j.eururo.2020.10.007openalex-extracted
Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis
inferredcites →https://doi.org/10.1016/j.eururo.2021.01.021openalex-extracted
Collaborative Review: Factors Influencing Treatment Decisions for Patients with a Localized Solid Renal Mass
inferredcites →https://doi.org/10.1016/j.eururo.2022.03.006openalex-extracted
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update
inferredcites →https://doi.org/10.1016/j.eururo.2022.06.016openalex-extracted
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
inferredcites →https://doi.org/10.1016/j.eururo.2022.09.026openalex-extracted
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel
inferredcites →https://doi.org/10.1016/j.eururo.2023.04.003openalex-extracted
Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/j.humpath.2015.07.001openalex-extracted
Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome
inferredcites →https://doi.org/10.1016/j.juro.2008.06.014openalex-extracted
External Validation of the Mayo Clinic Cancer Specific Survival Score in a Japanese Series of Clear Cell Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/j.juro.2009.12.035openalex-extracted
Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/j.juro.2010.03.026openalex-extracted
Development and External Validation of a Nomogram Predicting Disease Specific Survival After Nephrectomy for Papillary Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/j.juro.2011.02.059openalex-extracted
Independent Validation of the 2010 American Joint Committee on Cancer TNM Classification for Renal Cell Carcinoma: Results From a Large, Single Institution Cohort
inferredcites →https://doi.org/10.1016/j.juro.2012.09.166openalex-extracted
Lymphopenia is an Independent Predictor of Inferior Outcome in Clear Cell Renal Carcinoma
inferredcites →https://doi.org/10.1016/j.urolonc.2015.04.011openalex-extracted
Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation
inferredcites →https://doi.org/10.1016/j.urolonc.2019.02.014openalex-extracted
External validation of the updated Leibovich prognostic models for clear cell and papillary renal cell carcinoma in an Asian population
inferredcites →https://doi.org/10.1016/j.urolonc.2021.05.028openalex-extracted
Prognostic nutritional index and prognosis in renal cell carcinoma: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/j.urolonc.2023.07.011openalex-extracted
Assessing the impact of lymphovascular invasion on overall survival in surgically treated renal cell carcinoma patients: A nationwide cohort analysis
inferredcites →https://doi.org/10.1016/s0022-5347(05)64153-5openalex-extracted
An Outcome Prediction Model for Patients with Clear Cell Renal Cell Carcinoma Treated with Radical Nephrectomy Based on Tumor Stage, Size, Grade and Necrosis: The Ssign Score
inferredcites →https://doi.org/10.1016/s0022-5347(05)66077-6openalex-extracted
A POSTOPERATIVE PROGNOSTIC NOMOGRAM FOR RENAL CELL CARCINOMA
inferredcites →https://doi.org/10.1016/s0022-5347(17)62331-0openalex-extracted
The Results of Radical Nephrectomy for Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/s0022-5347(17)64494-xopenalex-extracted
Radical Nephrectomy for Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/s1470-2045(15)70167-1openalex-extracted
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies
inferredcites →https://doi.org/10.1038/modpathol.2015.6openalex-extracted
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype
inferredcites →https://doi.org/10.1038/nrc1478openalex-extracted
Why do cancers have high aerobic glycolysis?
inferredcites →https://doi.org/10.1038/nrclinonc.2018.8openalex-extracted
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
inferredcites →https://doi.org/10.1038/s41379-019-0273-1openalex-extracted
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases
inferredcites →https://doi.org/10.1038/s41430-021-01014-0openalex-extracted
The prognostic significance of controlling nutritional status (CONUT) score for surgically treated renal cell cancer and upper urinary tract urothelial cancer: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1038/s41571-019-0222-4openalex-extracted
Tumour-associated neutrophils in patients with cancer
inferredcites →https://doi.org/10.1038/s41577-019-0202-zopenalex-extracted
Patrolling the vascular borders: platelets in immunity to infection and cancer
inferredcites →https://doi.org/10.1080/01635581.2019.1621357openalex-extracted
A Low Geriatric Nutritional Risk Index is Associated with Aggressive Pathologic Characteristics and Poor Survival after Nephrectomy in Clear Renal Cell Carcinoma: A Multicenter Retrospective Study
inferredcites →https://doi.org/10.1093/ajcp/110.6.782openalex-extracted
Discriminant Nuclear Features of Renal Oncocytoma and Chromophobe Renal Cell Carcinoma: Analysis of Their Potential Utility in the Differential Diagnosis
inferredcites →https://doi.org/10.1093/ajcp/aqab136openalex-extracted
Prognostic Significance of Percentage Necrosis in Clear Cell Renal Cell Carcinoma
inferredcites →https://doi.org/10.1093/annonc/mdx492openalex-extracted
Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial population
inferredcites →https://doi.org/10.1093/oncolo/oyad218openalex-extracted
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker
inferredcites →https://doi.org/10.1097/00000478-198210000-00007openalex-extracted
Prognostic significance of morphologic parameters in renal cell carcinoma
inferredcites →https://doi.org/10.1097/00008469-200204000-00010openalex-extracted
Global increases in kidney cancer incidence, 1973–1992
inferredcites →https://doi.org/10.1097/01.ju.0000148261.19532.2copenalex-extracted
A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA
inferredcites →https://doi.org/10.1097/01.ju.0000158043.94525.d6openalex-extracted
INDEPENDENT VALIDATION OF THE 2002 AMERICAN JOINT COMMITTEE ON CANCER PRIMARY TUMOR CLASSIFICATION FOR RENAL CELL CARCINOMA USING A LARGE, SINGLE INSTITUTION COHORT
inferredcites →https://doi.org/10.1097/01.pas.0000249446.28713.53openalex-extracted
Fuhrman Grading is not Appropriate for Chromophobe Renal Cell Carcinoma
inferredcites →https://doi.org/10.1097/cji.0000000000000055openalex-extracted
Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC)
inferredcites →https://doi.org/10.1097/js9.0000000000000524openalex-extracted
Prognostic value of preoperative serum cystatin-C level for non-metastatic renal cell carcinoma—correspondence
inferredcites →https://doi.org/10.1097/pas.0000000000000690openalex-extracted
Tumor Necrosis Adds Prognostically Significant Information to Grade in Clear Cell Renal Cell Carcinoma
inferredcites →https://doi.org/10.1097/pas.0b013e3181e96f2aopenalex-extracted
A Novel Tumor Grading Scheme for Chromophobe Renal Cell Carcinoma
inferredcites →https://doi.org/10.1097/pas.0b013e318299f0fbopenalex-extracted
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
inferredcites →https://doi.org/10.1111/bju.13414openalex-extracted
Plasma fibrinogen level: an independent prognostic factor for disease‐free survival and cancer‐specific survival in patients with localised renal cell carcinoma
inferredcites →https://doi.org/10.1111/bju.13424openalex-extracted
Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model
inferredcites →https://doi.org/10.1111/his.13311openalex-extracted
Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading
inferredcites →https://doi.org/10.1111/his.13737openalex-extracted
Assessment of tumour‐associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma
inferredcites →https://doi.org/10.1111/iju.14266openalex-extracted
Contact with renal sinus is associated with poor prognosis in surgically treated pT1 clear cell renal cell carcinoma
inferredcites →https://doi.org/10.1111/j.1365-2559.2012.04228.xopenalex-extracted
SMARCB1/INI1 inactivation in renal medullary carcinoma
inferredcites →https://doi.org/10.1111/j.1442-2042.2009.02353.xopenalex-extracted
Urinary collecting system invasion in renal cell carcinoma: Incidence and long‐term prognosis
inferredcites →https://doi.org/10.1111/j.1464-410x.2008.08236.xopenalex-extracted
Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences
inferredcites →https://doi.org/10.1111/j.1464-410x.2012.11366.xopenalex-extracted
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma
inferredcites →https://doi.org/10.1155/2015/145647openalex-extracted
C-Reactive Protein and Breast Cancer: New Insights from Old Molecule
inferredcites →https://doi.org/10.1159/000050968openalex-extracted
Prognostic Value of Renal Cell Carcinoma Nuclear Grading: Multivariate Analysis of 333 Cases
inferredcites →https://doi.org/10.1182/blood.v96.10.3302openalex-extracted
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
inferredcites →https://doi.org/10.1186/s12885-018-4773-zopenalex-extracted
Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1186/s12885-021-07883-9openalex-extracted
Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~
inferredcites →https://doi.org/10.1186/s12894-018-0333-8openalex-extracted
Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy
inferredcites →https://doi.org/10.1186/s12894-021-00796-6openalex-extracted
Preoperative anaemia and thrombocytosis predict adverse prognosis in non‐metastatic renal cell carcinoma with tumour thrombus
inferredcites →https://doi.org/10.1186/s12916-019-1419-1openalex-extracted
The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort
inferredcites →https://doi.org/10.1200/jco.2001.19.6.1649openalex-extracted
Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System
inferredcites →https://doi.org/10.1200/jco.2002.05.111openalex-extracted
Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell Carcinoma
inferredcites →https://doi.org/10.1200/jco.2004.09.104openalex-extracted
Use of the University of California Los Angeles Integrated Staging System to Predict Survival in Renal Cell Carcinoma: An International Multicenter Study
inferredcites →https://doi.org/10.1200/jco.2005.07.055openalex-extracted
Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience
inferredcites →https://doi.org/10.1200/jco.2006.06.1218openalex-extracted
Multi-Institutional Validation of a New Renal Cancer–Specific Survival Nomogram
inferredcites →https://doi.org/10.1245/s10434-020-08417-6openalex-extracted
Prognostic Implication of Body Mass Index on Survival Outcomes in Surgically Treated Nonmetastatic Renal Cell Carcinoma: A Single-Institutional Retrospective Analysis of a Large Cohort
inferredcites →https://doi.org/10.1371/journal.pone.0166482openalex-extracted
Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.1371/journal.pone.0224266openalex-extracted
C-reactive protein to albumin ratio predicts the outcome in renal cell carcinoma: A meta-analysis
inferredcites →https://doi.org/10.1517/14712598.3.7.1105openalex-extracted
The role of fibrinogen and related fragments in tumour angiogenesis and metastasis
inferredcites →https://doi.org/10.21037/tau-19-873openalex-extracted
The predictive value of the preoperative fibrinogen-albumin ratio on the postoperative prognosis of renal cell carcinoma
inferredcites →https://doi.org/10.2147/ott.s108469openalex-extracted
Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis
inferredcites →https://doi.org/10.21873/anticanres.11677openalex-extracted
Prognostic Significance of Preoperative Anemia in Patients Undergoing Surgery for Renal Cell Carcinoma: A Meta-analysis
inferredcites →https://doi.org/10.3322/caac.21660openalex-extracted
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
inferredcites →https://doi.org/10.3389/fonc.2021.780906openalex-extracted
Potential Clinical Value of Pretreatment De Ritis Ratio as a Prognostic Biomarker for Renal Cell Carcinoma
inferredcites →https://doi.org/10.3389/fonc.2023.1210451openalex-extracted
Prognostic significance of albumin-to-globulin ratio in patients with renal cell carcinoma: a meta-analysis
inferredcites →https://doi.org/10.3390/cancers14235985openalex-extracted
High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma
inferredcites →https://doi.org/10.3892/ijo.2018.4294openalex-extracted
Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma
inferredcites →https://doi.org/10.6004/jnccn.2022.0001openalex-extracted
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
inferredcites →https://doi.org/10.7150/jca.31173openalex-extracted
Association of Preoperative Plasma D-dimmer and Fibrinogen and Renal Cell Carcinoma Outcome
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.